avail
treatment
mani
infecti
diseas
limit
particular
diseas
caus
viral
pathogen
demonstr
need
new
medicin
due
increas
appear
resist
avail
treatment
thousand
novel
compound
isol
variou
marin
organ
test
pharmacolog
properti
mani
commerci
avail
screen
natur
product
deriv
marin
speci
antivir
activ
yield
consider
number
activ
crude
aqueou
organ
solvent
extract
today
compound
commerci
avail
pharmacolog
market
includ
altern
antivir
medicin
test
potenti
antivir
drug
mani
test
potenti
antivir
drug
preclin
clinic
stage
grow
interest
marinederiv
antivir
compound
along
develop
new
technolog
marin
cultur
extract
significantli
expedit
current
explor
marin
environ
compound
signific
pharmacolog
applic
continu
promis
strategi
new
trend
modern
medicin
mankind
known
last
sever
thousand
year
marin
organ
contain
substanc
capabl
potent
biolog
activ
howev
first
seriou
investig
marin
organ
elion
et
al
araa
vidarabin
synthet
deriv
arabinosyl
nucleosid
spong
tethya
cripta
antivir
hsv
om
privat
de
garilh
de
rudder
arac
cytarabin
spong
tethya
cripta
antivir
hsv
om
privat
de
garilh
de
rudder
avarol
spong
disidea
avara
antivir
hiv
pcd
muller
et
al
muller
et
al
azidothymidin
zidovudin
synthet
deriv
arabinosyl
nucleosid
spong
tethya
cripta
antivir
hsv
hiv
om
horwitz
et
al
cyanovirinn
cyanobacteria
nostoc
ellipsosporum
antivir
siv
pcd
boyd
et
al
om
market
pcd
preclin
develop
past
year
marin
organ
provid
key
structur
compound
prove
potenti
industri
develop
cosmet
nutrit
supplement
fine
chemic
agrochem
therapeut
agent
varieti
diseas
tziveleka
et
al
past
year
thousand
novel
compound
metabolit
divers
biolog
activ
rang
anticanc
antivir
isol
variou
marin
sourc
current
use
tabl
arif
et
al
current
appear
studi
focus
find
bioactiv
compound
deriv
marin
bacteria
use
antitumor
agent
well
agent
infecti
organ
structur
function
divers
bioactiv
compound
isol
prokaryot
includ
member
myxobacteria
eg
sorangium
cyanobacteria
eg
nostoc
magarvey
et
al
studi
aim
identifi
bioactiv
compound
marin
bacteria
center
bacteria
order
actinomycetal
well
bacteri
product
exopolysaccharid
cyanobacteria
consid
eukaryoto
alga
magarvey
et
al
arena
et
al
arena
et
al
order
actinomycetal
compos
approxim
genera
divers
actinomycet
secondari
metabolit
unriv
unmatch
medic
signific
account
antibiot
identifi
date
magarvey
et
al
prudhomm
et
al
pure
activ
compound
extract
marin
actinomycet
salinispora
tropica
shown
inhibitori
effect
mani
malign
cell
type
prudhomm
et
al
particular
salinosporamid
relat
known
proteasom
inhibitor
omuralid
shown
potent
inhibitor
human
multipl
meyloma
fele
et
al
salinosporamid
begun
phase
clinic
trial
potent
inhibitor
divid
melanoma
cell
possess
uniqu
abil
inhibit
proteolyt
activ
proteasom
subunit
without
affect
proteas
prudhomm
et
al
test
salinosporamid
util
antimalari
drug
salinosporamid
shown
inhibitori
activ
parasit
develop
vitro
plasmodium
falciparum
vivo
p
yoelii
exact
mode
salinosporamid
inhibit
plasmodium
erythrocyt
develop
unknown
howev
like
due
inhibit
proteasom
complex
interest
note
chloroquin
resist
strain
still
sensit
salinosporamid
target
proteasom
system
huge
therapeut
implic
restrain
growth
surviv
cell
type
prudhomm
et
al
attribut
taken
fact
alreadi
phase
clinic
trial
antitumor
agent
make
excel
candid
test
altern
therapi
antibacteri
antiparasit
antifung
antivir
agent
microand
macroalga
one
first
sourc
natur
compound
show
vitro
antihiv
activ
schaeffer
krylov
alga
includ
wide
varieti
plant
rang
diatom
microscop
unicellular
organ
seawe
extend
mani
econom
import
food
fertil
agar
potash
sourc
iodin
antibacteri
activ
aquat
microalga
first
report
chlorella
vulgari
pratt
fong
earli
report
antimicrobi
properti
seawe
extract
publish
decad
later
pratt
et
al
sever
paper
appear
next
two
decad
burkhold
sharma
pharmaceut
interest
spong
aros
earli
discoveri
nucleosid
spongothymidin
spongouridin
marin
spong
cryptotethia
crypta
feeney
nucleosid
basi
synthesi
arac
first
marinederiv
anticanc
agent
antivir
drug
araa
privat
de
garilh
de
rudder
arac
current
use
routin
treatment
patient
leukemia
lymphoma
one
fluorin
deriv
also
approv
use
patient
pancreat
breast
bladder
lung
cancer
sipkema
et
al
respect
divers
secondari
metabolit
marin
spong
sinc
consid
gold
mine
marin
product
describ
spong
respons
differ
product
hundr
new
compound
discov
everi
year
sipkema
et
al
chemic
divers
spong
product
remark
addit
unusu
nucleosid
bioactiv
terpen
sterol
cyclic
peptid
alkaloid
fatti
acid
peroxid
amino
acid
deriv
frequent
halogen
describ
spong
sipkema
et
al
tziveleka
et
al
earli
appear
evolut
given
lot
time
develop
advanc
chemic
defens
system
interest
note
synthesi
secondari
metabolit
regul
depend
condit
spong
experi
huge
number
differ
secondari
metabolit
discov
marin
spong
complex
compound
biosynthet
pathway
correspond
kilobas
dna
program
synthesi
regard
indic
import
surviv
sipkema
et
al
spong
role
chemic
constitu
cloud
complex
spongesymbiont
relationship
mani
differ
bacteri
speci
perman
inhabit
spong
contribut
gustafson
et
al
b
consider
total
spong
biomass
suggest
growth
use
microorgan
may
control
spong
host
serv
sourc
food
suppli
metabol
product
howev
also
found
associ
bacteria
might
actual
produc
number
compound
isol
spong
sipkema
et
al
oscillatoria
spongelia
cyanobacteri
symbiont
constitut
dysidea
herbacea
produc
antimicrobi
polybromin
biphenyl
ether
might
keep
spong
free
bacteria
unson
et
al
interest
turn
marin
microorgan
marin
fungi
prove
rich
promis
sourc
novel
bioactiv
natur
product
microorgan
grow
uniqu
extrem
habitat
therefor
capabl
produc
uniqu
unusu
secondari
metabolit
believ
metabolit
possibl
act
chemic
defens
adapt
fungi
compet
substrat
product
uniqu
secondari
metabolit
marin
fungi
like
due
adapt
distinct
set
environment
pressur
bhaduri
et
al
date
new
compound
isol
marin
fungi
number
compound
increas
bugni
ireland
metabolit
analogu
discov
previous
terrestri
fungi
metabolit
potenti
clinic
import
could
produc
bulk
total
semisynthet
pathway
implement
ferment
technolog
use
post
genom
technolog
biosynthet
gene
cluster
clone
express
vector
system
bhaduri
et
al
marin
fungalderiv
compound
sargassamid
halimid
avrainvillamid
shown
select
inhibit
cancer
cell
line
show
vivo
activ
preclin
model
lymphocyt
leukemia
http
wwwcancerucsdedusummarieswfenicalasp
two
potenti
drug
licens
pharmaceut
industri
preclin
develop
divers
natur
product
marin
fungi
clearli
demonstr
potenti
transfer
compound
clinic
trial
futur
develop
antiinfect
drug
bhaduri
et
al
marin
antivir
agent
mava
repres
significantli
uniqu
natur
marin
resourc
whose
multipotenti
use
includ
follow
applic
biolog
control
human
enteropathogen
viru
contamin
diseas
transmiss
sewagepollut
water
applic
would
particularli
import
commun
util
coastal
water
recreat
activ
food
industri
eg
fish
shellfish
well
region
countri
hawaii
loss
marin
resourc
would
devast
effect
lifestyl
economi
peopl
chemotherapi
viral
diseas
human
lower
anim
practic
use
imper
mava
isol
pure
cultur
identifi
character
spectrum
mechan
antivir
activ
clearli
establish
also
activ
principl
moieti
identifi
chemic
character
order
facilit
applic
biotechnolog
method
increas
yield
cost
effect
product
biolog
control
viral
diseas
marin
anim
natur
condit
practic
way
prevent
viral
transmiss
marin
mammal
especi
troublesom
marin
mammal
kept
captiv
variou
use
seed
mava
special
environ
could
control
viral
diseas
transmiss
current
appear
compound
deriv
marin
bacteria
antivir
activ
tabl
keep
mind
cyanobacteria
tradit
group
bluegreen
alga
studi
use
marin
bacteria
sourc
antivir
compound
focus
mainli
marin
bacteri
exopolysaccharid
arena
et
al
arena
et
al
mani
marin
bacteria
produc
exopolysaccharid
ep
strategi
growth
adher
solid
surfac
surviv
advers
condit
grow
interest
isol
new
exopolysaccharideproduc
bacteria
marin
environ
particularli
exist
extrem
marin
environ
character
extrem
pressur
temperatur
well
high
concentr
h
heavi
metal
vincent
et
al
bacteria
deepsea
hydrotherm
vent
alteromona
macleodii
subsp
fijiensi
vibrio
diabolicu
alteromona
infernu
strain
produc
ep
origin
structur
enabl
surviv
extrem
environ
arena
et
al
bacteri
ep
produc
environ
provid
novel
chemic
composit
properti
structur
potenti
applic
differ
industri
field
recent
hydrothermophil
thermotoga
maritima
thermococcu
litorali
report
produc
extra
polysacchard
rinker
kelli
exopolysaccharid
sulphat
exopolysaccharid
ep
known
interfer
adsorpt
penetr
virus
host
cell
well
inhibit
variou
retrovir
revers
transcriptas
two
new
exopolysaccharid
isol
bacillu
licheniformi
geobacillu
thermodenitrifican
respect
two
bacteria
isol
shallow
marin
hot
spring
vulcano
island
itali
arena
et
al
arena
et
al
two
ep
shown
noncytotox
pbmc
wish
cell
concentr
gml
antivir
effect
produc
concentr
gml
shown
significantli
reduc
viral
titer
determin
abl
inhibit
replic
pbmc
upregul
express
proinflammatori
cytokin
particularli
trigger
polar
favor
subset
arena
et
al
arena
et
al
macrolactin
anoth
marin
bacteriaderiv
antivir
compound
includ
ring
lacton
relat
glucos
open
chain
acid
show
protect
human
tlymphoblast
cell
human
hiv
replic
maximum
protect
concentr
gml
gustafson
et
al
hayashi
et
al
cyanovirinn
cyanobacteria
nostoc
ellipsosporum
siv
fusion
replic
cpe
boyd
et
al
compound
extract
alga
vitro
vivo
activ
wide
rang
virus
includ
herp
virus
hcmv
togavirus
sindbi
viru
semliki
forest
viru
paramyxovirus
rsv
rhabdovirus
vsv
human
simian
immun
defici
virus
hiv
siv
tabl
antivir
effect
polysaccharid
marin
alga
toward
mump
influenza
b
viru
report
year
ago
gerber
et
al
subsequ
polysaccharid
fraction
extract
red
alga
found
inhibit
hsv
virus
burkhold
sharma
dieg
ehresmann
et
al
richard
et
al
howev
observ
gener
much
interest
antivir
action
compound
consid
larg
nonspecif
witvrouw
de
clercq
isol
alga
sulfat
polysaccharid
compound
antivir
activ
envelop
virus
increas
interest
alga
sourc
antivir
compound
galactan
sulfat
galactan
sulfat
gs
polysaccharid
isol
red
seawe
agardhiella
tenera
show
activ
witvrouw
et
al
viralinduc
cpe
cell
inhibit
ic
valu
gl
respect
viralinduc
syncytia
format
cell
cell
inhibit
gs
concentr
gl
gs
inhibit
bind
cell
well
bind
mab
gs
also
activ
envelop
virus
includ
herp
virus
togavirus
arenavirus
other
witvrouw
et
al
extracellular
sulfat
polysaccharid
isol
purifi
cochlodinium
polykrikoid
marin
microalga
hasui
et
al
inhibit
cytopath
effect
influenza
viru
type
b
grown
mdck
cell
rsv
type
b
grown
cell
cell
ic
valu
gml
also
activ
activ
parainfluenza
viru
type
cell
noncytotox
gml
produc
weak
inhibitori
effect
blood
coagul
concentr
inhibitori
viru
hasui
et
al
fucoidan
sulfat
polysaccharid
isol
brown
seawe
fucu
vesiculosu
et
al
show
inhibitori
effect
replic
dna
virus
herp
viru
hcmv
baba
et
al
et
al
moen
clark
compound
also
activ
rna
virus
vsv
sinbi
viru
baba
et
al
howev
compound
activ
coxsackieviru
polioviru
parainfluenza
viru
watersolubl
noncarbohydr
compon
fucoidan
isol
f
vesiculosu
abl
inhibit
hiv
rt
vitro
gml
moen
clark
preincub
cellfre
viru
gml
caus
reduct
amount
antigen
releas
test
show
effect
due
kill
target
cell
fact
fucoidan
produc
advers
effect
cell
prolifer
protein
metabol
preincub
target
cell
fucoidan
actual
protect
infect
moen
clark
addit
antivir
activ
fucoidan
possess
low
anticoagul
properti
baba
et
al
et
al
moen
clark
sea
algal
extract
nakashima
et
al
prepar
citrat
buffer
extract
marin
red
alga
schizymenia
pacifca
cellfre
system
use
test
effect
extract
revers
transcriptas
rt
avian
myelblastosi
viru
amv
rauscher
murin
leukemia
viru
nakashima
et
al
purifi
new
rt
inhibitor
pacifca
compound
term
sea
algal
extract
sae
sulfat
polysaccharid
compos
galactos
sulfon
sae
determin
specif
inhibitor
hiv
rt
hiv
replic
vitro
produc
advers
effect
cell
growth
sulfat
residu
hypothes
play
key
role
rt
inhibit
hypothesi
support
induc
activ
polysaccharid
nakashima
et
al
calcium
spirulan
like
alga
number
cyanobacteria
speci
found
produc
highli
antihiv
activ
sulfoglycolipid
gustafson
et
al
loya
et
al
reshef
et
al
addit
activ
sulfoglycolipid
constitut
part
chloroplast
membran
therefor
abund
harwood
calcium
spirulan
casp
sulfat
polysaccharid
isol
marin
bluegreen
alga
arthrospira
platensi
previous
call
spirulina
platensi
hayashi
et
al
hayashi
et
al
demonstr
casp
potent
antivir
agent
cell
ic
valu
cytotox
casp
cell
gml
viral
replic
reduc
ed
valu
gml
casp
ad
cell
medium
immedi
h
prior
infect
respect
casp
subsequ
found
inhibit
replic
sever
araaarac
vidarabinecytarabin
synthet
deriv
arabinosyl
nucleosid
tethya
cripta
disidea
avara
synthesi
natur
uag
suppressor
glutamin
transfer
trna
cross
bloodbrain
barrier
muller
et
al
muller
et
al
azidothymidin
sun
et
al
virus
includ
hcmv
hel
cell
hela
cell
measl
vero
cell
mump
vero
cell
influenza
mdck
cell
polio
vero
cell
coxsacki
viru
vero
cell
select
block
penetr
viru
host
cell
casp
also
low
anticoagul
activ
hayashi
et
al
cyanovirinn
cyanovirinn
cvn
initi
isol
aqueou
cellular
extract
cyanobacterium
nostoc
ellipsosporum
boyd
et
al
use
bioassayguid
fraction
parish
et
al
cyanovirinn
amino
acid
antivir
peptid
nsc
boyd
et
al
gustafson
et
al
unlik
protein
thu
far
character
low
nanomolar
concentr
cvn
prevent
vitro
replic
cytopath
effect
primat
retrovirus
includ
siv
divers
laboratori
strain
clinic
isol
bewley
et
al
cvn
mediat
antivir
effect
appar
conserv
interact
viral
envelop
glycoprotein
boyd
et
al
cnv
effect
prevent
celltocel
fusion
transmiss
hiv
infect
uninfect
cell
pretreat
hiv
virion
irrevers
neutral
viru
infect
toxic
host
cell
us
nation
cancer
institut
nci
select
novel
antihiv
agent
preclin
develop
potenti
prophylact
viricid
boyd
et
al
first
propos
cyanovirin
inactiv
hiv
interact
viru
surfac
envelop
glycoprotein
marin
et
al
found
cvn
block
bind
lysat
attach
intact
virion
sever
target
tcell
line
conclud
virucid
effect
cvn
result
interfer
step
fusion
process
subsequ
initi
bind
viru
target
cell
naviculan
sulfat
polysaccharid
naviculan
isol
navicula
directa
diatom
collect
deepsea
water
toyama
bay
japan
lee
et
al
compound
shown
inhibit
ic
gml
interf
earli
stage
viral
replic
like
affect
viral
adhes
penetr
host
cell
griffithsin
potent
hivinactiv
protein
griffithsin
isol
red
alga
griffithsia
sp
griffithsin
new
type
lectin
display
potent
antivir
activ
laboratori
strain
primari
isol
ic
nm
mori
et
al
activ
requir
bind
viral
glycoprotein
eg
monosaccharidedepend
manner
spong
also
rich
sourc
compound
antivir
properti
tabl
high
number
hivinhibit
compound
isol
spong
reflect
increas
potenti
fight
aid
comparison
viral
diseas
rather
show
interest
mani
research
strong
focu
screen
spong
antihiv
activ
led
discoveri
numer
compound
howev
mechan
inhibit
still
poorli
character
papuamid
c
ford
et
al
haplosam
b
qureshi
faulkner
avarol
muller
et
al
muller
et
al
muller
schroder
also
patent
antipsoriasi
drug
exampl
hivinhibit
compound
differ
spong
avarol
one
compound
mechan
inhibit
progress
hiv
infect
less
known
muller
et
al
muller
et
al
vitro
anim
data
indic
avarol
combin
use
properti
increas
humor
immun
respons
igg
igm
product
significantli
increas
interfer
posttranscript
process
viral
infect
minagawa
et
al
b
avarol
inhibit
hiv
almost
complet
block
synthesi
natur
uag
suppressor
glutamin
transfer
trna
muller
schroder
synthesi
trna
upregul
viral
infect
import
synthesi
viral
proteas
necessari
viral
prolifer
low
concentr
avarol
result
inhibit
viral
releas
infect
cell
respect
uninfect
cell
highli
resist
avarol
muller
et
al
muller
et
al
muller
schroder
spong
metabolit
avarol
avaron
avarol
deriv
hydroxi
avarol
hydroxi
avaron
sever
phloroglucinol
deriv
muller
et
al
muller
et
al
muller
schroder
report
interact
revers
transcriptas
along
illimaquinon
loya
hizi
target
rnase
h
function
revers
transcriptas
import
contribut
marin
environ
area
isol
character
arabinosyl
nucleosid
spong
tethya
cripta
use
model
synthesi
araa
vidarabin
use
therapeut
herpet
enceph
sinc
late
privat
de
garilh
de
rudder
exampl
product
semisynthet
modif
arabinosyl
nucleosid
arac
cytarabin
privat
de
garilh
de
rudder
acyclovir
elion
et
al
azidothymidin
zidovudin
horwitz
et
al
nowaday
clinic
use
tabl
part
search
novel
influenza
viru
neuraminidas
inhibitor
three
activ
sulfat
calyceramid
ac
isol
marin
spong
discodermia
calyx
nakao
et
al
interestingli
calyceramid
ac
inhibit
neuraminidas
bacterium
clostridium
perfringen
ic
valu
gml
respect
valu
slightli
potent
neuramin
acid
ic
mgml
remain
determin
compound
also
inhibit
influenza
viru
neuraminidas
similar
potenc
nakao
et
al
year
much
attent
turn
toward
hiv
research
clathsterol
novel
activ
sulfat
sterol
red
sea
spong
clathria
sp
shown
activ
rt
rudi
et
al
hivinhibitori
cyclic
depsipeptid
microspinosamid
isol
marin
spong
sidonop
microspinosa
rashid
et
al
microspinosamid
inhibit
cytopath
effect
infect
cellbas
vitro
assay
ec
valu
gml
howev
compound
cytoprotect
modest
concentr
rang
due
cytotox
effect
toward
host
cell
ic
valu
approxim
gml
rashid
et
al
extens
studi
perform
mechan
action
polyacetylenetriol
isol
marin
spong
petrosia
sp
loya
et
al
polyacetylenetriol
show
select
inhibit
rnaand
dnadepend
dna
polymeras
activ
retrovir
rt
ic
compar
cellular
dna
polymeras
ic
furthermor
revers
noncompetit
mechan
involv
put
hydrophob
interact
shown
play
critic
role
inhibit
rt
enzym
although
polyacetylenetriol
lack
suffici
specif
thu
could
probabl
use
antihiv
agent
conclud
structur
modif
side
chain
lead
polyacetylen
molecul
might
produc
new
potent
select
antiaid
drug
loya
et
al
new
polycycl
guanidin
alkaloid
crambescidin
report
marin
spong
monanchora
sp
chang
et
al
crambescidin
inhibit
envelopemedi
fusion
vitro
ic
thu
suggest
class
compound
might
ultim
aid
ration
design
small
molecul
fusion
inhibitor
chang
et
al
new
furanoterpen
isol
madagascan
lendenfeldia
spong
design
dehydrofurodendin
activ
rtassoci
rnaand
dnadirect
dna
polymeras
ic
chill
et
al
new
hivinhibitori
depsiundecapeptid
neamphamid
isol
papua
new
guinea
marin
spong
neamphiu
huxleyi
oku
et
al
neamphamid
potent
inhibit
cytopath
effect
infect
cellbas
vitro
assay
ec
nm
hiv
inhibit
report
two
bisquinolizidin
alkaloid
petrosin
isol
indian
marin
spong
petrosia
simil
goud
et
al
extens
investig
determin
petrosin
inhibit
replic
ic
format
giant
cell
ic
recombin
revers
transcriptas
vitro
ic
goud
et
al
compound
hamigeran
b
hamigera
tarangaensi
show
vitro
inhibit
herp
polio
virus
wellington
et
al
weinbersterol
b
petrosia
weinbergi
exhibit
vitro
activ
felin
leukemia
viru
mous
influenza
viru
mous
corona
viru
sun
et
al
search
antivir
compound
marin
fungi
yield
promis
result
tabl
compound
like
equisetin
phomasetin
isol
marin
fungi
fusarium
heterosporum
phoma
sp
respect
shown
signific
integras
inhibit
bioassaybas
experi
ic
singh
et
al
sansalvamid
cyclic
depsipeptid
isol
marin
fungu
fusarium
sp
found
inhibit
topoisomeras
pathogen
poxviru
molluscum
contagiosum
mcv
prevent
topoisomeras
catalyz
dna
relax
dnabind
coval
complex
format
ic
hwang
et
al
isol
identif
metabolit
particularli
signific
mcv
caus
sever
lesion
aid
patient
bhaduri
et
al
seri
novel
linear
peptid
halovir
ae
isol
marin
fungu
scytidium
sp
shown
potent
antivir
activ
rowley
et
al
ed
valu
durat
halovir
b
c
e
respect
standard
plaqu
reduct
assay
halovir
equal
inhibit
replic
ed
valu
nm
mode
action
still
clear
howev
rowley
et
al
presum
halovir
render
hsv
noninfecti
possibl
membran
destabil
rowley
et
al
stachyflin
novel
terpenoid
isol
fungu
stachybotri
sp
show
vitro
antivir
activ
influenza
viru
ic
valu
significantli
better
drug
amantadin
zanamivir
minagawa
et
al
minagawa
et
al
stachyflin
pentacycl
moieti
includ
novel
cisfus
decalin
antivir
activ
mediat
inhibit
fusion
viral
envelop
host
cell
membran
activ
thought
uniqu
among
antivir
compound
minagawa
et
al
b
addit
marin
microorgan
sever
marin
macroorgan
examin
presenc
compound
antihiv
activ
tabl
tachypesin
polyphemusin
peptid
tachyplesin
iiii
polyphemusin
ii
highli
abund
hemocyt
debri
horsesho
crab
tachypleu
tridentatu
limulu
polyphemu
respect
found
hivcel
fusion
inhibitor
miyata
et
al
morimoto
et
al
synthet
peptid
analogu
mention
metabolit
synthes
test
synthet
peptid
analog
polyphemusin
ii
limulu
polyphemu
show
strong
antihiv
activ
rel
low
vitro
cytotox
ec
compar
azt
morimoto
et
al
thalassiolin
ac
sulfatedflavon
glycosid
isol
caribbean
sea
grass
thalassia
testudinum
rowley
et
al
thalassiolin
activ
compound
seri
inhibit
hiv
replic
cell
cultur
ic
target
integrasecatalyz
strand
transfer
ic
interestingli
presenc
sulfat
glucos
function
increas
potenc
hiv
integras
molecular
model
studi
indic
probabl
bind
site
molecul
catalyt
core
domain
integras
rowley
et
al
inhibitor
integras
didemnaket
b
isol
ascidian
didemnum
sp
found
inhibitor
proteas
ic
valu
respect
pott
et
al
bioassayguid
fraction
extract
palauan
ascidian
didemnum
guttatum
led
isol
cyclodidemniserinol
trisulf
inhibitor
integras
ic
gml
mitchel
et
al
compound
also
inhibit
mcv
topoisomeras
ic
gml
show
select
integras
inhibit
lamellarin
isol
arabian
sea
ascidian
reddi
et
al
lamellarin
first
isol
prosobranch
mollusk
genu
lamellaria
subsequ
obtain
didemnid
ascidian
andersen
et
al
lamellarin
anoth
inhibitor
integras
compound
inhibit
integras
termin
cleavag
activ
ic
strand
transfer
activ
ic
reddi
et
al
polyciton
loya
et
al
aromat
alkaloid
isol
ascidian
polycitor
sp
exhibit
potent
inhibitori
impact
rna
ic
nm
dnadirect
dna
polymeras
ic
nm
polyciton
interfer
dna
primer
extens
well
format
rtdna
complex
loya
et
al
antihsv
compound
alkaloid
eudistomin
isol
tunic
eudistoma
olivaceum
along
relat
exhibit
activ
hudson
et
al
marin
antivir
compound
call
didemnin
cyclic
depsipeptid
isol
trididemnum
speci
tunic
show
vitro
vivo
antivir
properti
along
virus
caus
rift
valley
fever
venezuelan
equin
encephalomyel
yellow
fever
use
natur
product
manufactur
drug
ancient
wellestablish
practic
yield
familiar
product
morphin
digitali
penicillin
aspirin
roussi
marin
environ
repres
approxim
half
global
biodivers
estim
contain
million
differ
speci
offer
almost
infinit
resourc
novel
compound
tziveleka
et
al
report
ocean
contain
global
phyla
possess
nearli
describ
speci
plant
anim
repres
small
percentag
total
number
speci
yet
discov
bhaduri
et
al
da
silva
et
al
marin
microorgan
known
produc
pharmacolog
antivir
agent
may
provid
unlimit
biolog
resourc
product
therapeut
drug
treatment
control
viral
diseas
human
livestock
marin
farm
speci
well
ever
novel
compound
potenti
pharmaceut
nutrit
supplement
cosmet
agrichem
enzym
strong
potenti
market
valu
tabl
bhaduri
et
al
addit
ecolog
pressur
competit
space
predat
symbiosi
tide
variat
throughout
thousand
year
origin
biosynthesi
complex
secondari
metabolit
organ
turn
allow
adapt
competit
hostil
environ
da
silva
et
al
current
antivir
drug
armamentarium
compris
nearli
compound
offici
approv
clinic
use
drug
date
back
last
year
least
half
use
treatment
hiv
infect
da
silva
et
al
current
natur
product
promis
level
antihiv
activ
isol
aqueou
organ
extract
marin
organ
follow
bioassayguid
protocol
continu
search
test
natur
compound
antivir
potenti
like
lead
discoveri
develop
new
gener
antivir
agent
effect
control
viral
diseas
human
well
valuabl
anim
speci
insuffici
knowledg
condit
specif
paramet
growth
cultiv
marin
microor
macroorgan
discourag
pharmaceut
industri
pursu
commerci
marinederiv
bioactiv
molecul
difficulti
inher
marin
environ
initi
allow
research
focu
nearshor
easili
access
speci
collect
routin
method
scuba
dive
howev
advanc
marin
technolog
biotechnolog
along
develop
special
tool
remot
platform
man
submers
continu
allow
effici
systemat
explor
extrem
environ
addit
mainten
cultiv
rare
marin
speci
tziveleka
et
al
one
challeng
futur
largescal
product
compound
meet
demand
clinic
trial
drug
develop
believ
form
combinatori
genet
metabol
engin
futur
solut
commerci
product
compound
integr
combinatori
biochemistri
computerbas
molecular
model
design
along
postgenom
technolog
could
use
sustain
product
metabolit
alreadi
marin
metabolit
test
clinic
produc
either
aquacultur
eg
compound
like
bryostatin
chemic
synthesi
compound
like
dolastatin
ziconotid
halichondrin
b
deriv
etc
ferment
process
thiocoralin
munro
et
al
one
success
exampl
chemic
synthesi
corollosporin
antibacteri
metabolit
marin
fungu
corollospora
maritim
ohzeki
mori
chemic
synthesi
may
solut
compound
could
econom
nonviabl
other
bhaduri
et
al
largescal
cultiv
marin
fungi
use
bioreactor
technolog
mean
also
essenti
steadi
suppli
natur
product
marinebas
drug
market
ferment
process
gain
consider
import
last
year
commerci
product
metabolit
solidst
ferment
ssf
use
wide
product
biolog
activ
secondari
metabolit
fungi
combinatori
biosynthesi
involv
introduct
novel
biosynthesi
gene
microorgan
result
synthesi
novel
metabolit
due
effect
new
enzym
metabol
pathway
bhaduri
et
al
anoth
import
challeng
antivir
drug
develop
resist
variou
virus
howev
consid
numer
undiscov
organ
marin
environ
along
uniqu
metabolit
plausibl
increas
number
novel
drug
discov
virus
yet
develop
resist
also
import
note
mani
organ
differ
speci
produc
similar
class
compound
suit
uniqu
composit
live
environ
fact
vari
deriv
common
class
compound
produc
multipl
organ
may
solut
viru
develop
resist
particular
drug
may
resist
natur
occur
deriv
potenti
possess
similar
ident
antivir
activ
altern
found
occur
natur
applic
biochem
technolog
allow
manipul
natur
occur
compound
produc
chemic
deriv
far
superior
origin
bhaduri
et
al
allow
creation
compound
reduc
cytotox
increas
specif
discoveri
new
drug
well
adapt
current
drug
play
key
role
war
viral
resist
take
consider
discoveri
made
last
year
along
advanc
technolog
clear
marin
environ
play
vital
role
futur
develop
trial
antiinfect
drug
